Criteria for liver transplantation for HCC: What should the limits be?

Journal of Hepatology

Volumn 55, Issue 5, 2011, Pages 1137-1147

  Silva, Mauricio F ^a   Sherman, Morris ^b  

^a Hospital da Santa Casa   (Brazil)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Down staging; Evidence based medicine; Expanded criteria; Hepatocellular carcinoma; Liver transplantation; Milan criteria; Systematic review

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; DOXORUBICIN; YTTRIUM 90;

CADAVER DONOR; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CHEMOEMBOLIZATION; CHRONIC HEPATITIS; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; DILUTION; EVIDENCE BASED MEDICINE; GENE EXPRESSION PROFILING; HEPATITIS B; HOSPITAL ADMISSION; HUMAN; INTENTION TO TREAT ANALYSIS; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; MEDLINE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; SYSTEMATIC REVIEW; TREATMENT RESPONSE; TUMOR VOLUME;

EID: 80054749110     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.05.012     Document Type: Note

References (87)

1. H.B. El-Serag, and K.L. Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2007 2557 2576 (Pubitemid 46890874)
2. M.C. KEW Hepatic tumors and cysts 6th ed. M. Feldmen, M.H. Sleisenger, B.F. Schrschimidt, Sleisenger & Fordtran'sn gastrointestinal and liver disease: pathology/diagnosis/management vol. 1 1998 W.B. Saunders Philadelphia 1364 1367
3. M. Sherman Epidemiology of hepatocellular carcinoma Oncology 78 2010 7 10
4. J.M. Llovet, A.M. Di Bisceglie, J. Bruix, B.S. Kramer, R. Lencioni, and A.X. Zhu Panel of experts in HCC - design clinical trials. Design and endpoints of clinical trials in hepatocellular carcinoma J Natl Cancer Inst 100 2008 698 711
5. J. Bruix, M. Sherman, J.M. Llovet, M. Beaugrand, R. Lencioni, and A.K. Burroughs Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL conference J Hepatol 35 2001 421 430 (Pubitemid 32844200)
6. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2011 1208 1236
7. B. Ringe, R. Pichlmayr, C. Wittekind, and G. Tusch Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients World J Surg 15 1991 270 285
8. S. Iwatsuki, T.E. Starzl, D.G. Sheahan, I. Yokohama, A.J. Demetris, and S. Todo Hepatic resection versus transplantation for hepatocellular carcinoma Ann Surg 214 1991 221 228
9. H. Bismuth, L. Chiche, R. Adan, D. Castaing, T. Diamond, and A. Dennison Liver resection versus transplantation in cirrhotic patients with hepatocellular carcinoma in cirrhosis Ann Surg 218 1993 145 151 (Pubitemid 23229140)
10. V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, and F. Bozzetti Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Eng J Med 334 1996 693 699 (Pubitemid 26079803)
11. F.Y. Yao Expanded criteria for hepatocellular carcinoma: down-staging with a view to liver transplantation - Yes Semin Liver Dis 26 2006 239 247 (Pubitemid 44141931)
12. J.M. Llovet, M. Schwartz, J. Fuster, and J. Bruix Expanded criteria for hepatocellular carcinoma through down-staging prior to liver transplantation: not yet there Semin Liver Dis 26 2006 248 253 (Pubitemid 44141932)
13. F.Y. Yao, L. Ferrell, N.M. Bass, J.J. Watson, P. Bacchetti, and A. Venook Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology 33 2001 1394 1403 (Pubitemid 32496976)
14. J.I. Herrero, B. Sangro, J. Quiroga, F. Pardo, M. Herraiz, and J.A. Cienfuegos Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma Liver Transpl 7 2001 631 636 (Pubitemid 32677888)
15. S. Roayaie, J. Frischer, S.H. Emre, T.M. Fishbein, P.A. Sheiner, and M. Sung Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters Ann Surg 235 2002 533 539 (Pubitemid 34258353)
16. A. Khakhar, E. Solano, D. Stell, M. Bloch, C. Dale, and P. Burns Survival after liver transplantation for hepatocellular carcinoma Transplant Proc 35 2003 2438 2441 (Pubitemid 37378027)
17. J.A. Fernández, R. Rob, C. Marin, F. Sánchez Bueno, P. Ramirez, and J.A. Pons Can we expand the indications for liver transplantation among hepatocellular carcinoma patients with increased tumor size? Transpl Proc 35 2003 1818 1820 (Pubitemid 37093723)
18. J.W. Marsh, and I. Dvorchik Liver organ allocation for hepatocellular carcinoma: are we sure? Liver Transpl 9 2003 693 696 (Pubitemid 36874455)
19. M. Ravaioli, G. Ercolani, M. Cescon, G. Vetrone, C. Voci, and W.F. Grigioni Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria Liver Transpl 10 2004 1195 1202 (Pubitemid 39248420)
20. N.M. Kneteman, J. Oberholzer, M.A. Saghier, G.A. Meeberg, M. Blitz, and M.M. Ma Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma Liver Transpl 10 2004 1301 1311 (Pubitemid 39406087)
21. J.Y. Leung, A.X. Zhu, F.D. Gordon, D.S. Pratt, A. Mithoefer, and K. Garrigan Liver transplantation outcome for early-stage hepatocellular carcinoma: results of a multicenter study Liver Transpl 11 2004 1343 1354 (Pubitemid 39530049)
22. C. Zavaglia, L. De Carlis, A.B. Alberti, E. Minola, L.S. Belli, and A.O. Alim Predictors of long-term survival after liver transplantation for hepatocellular carcinoma Am J Gastroenterol 100 2005 2708 2716
23. F. Löhe, M.K. Angele, A.L. Gerbes, U. Löhrs, K.W. Jauch, and R.J. Schauer Tumour size is an important predictor for the outcome after liver transplantation for hepatocellular carcinoma Eur J Surg Oncol 31 2005 994 999 (Pubitemid 41671113)
24. T. Decaens, F. Roudot-Thoraval, S. Hadni-Bresson, C. Meyer, J. Gugenheim, and F. Durand Impact of UCLA criteria according to pre-and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time Liver Transpl 12 2006 1761 1769 (Pubitemid 44911801)
25. N. Onaca, L.D. Gary, R.M. Goldstein, L.W. Jennings, and G.B. Klintmalm Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation Liver Transpl 13 2007 391 399 (Pubitemid 46444468)
26. J.R. Parfitt, P. Marotta, M. Alghamdi, W. Wall, A. Khakhar, and N.G. Suskin Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence Liver Transpl 13 2007 543 551 (Pubitemid 46605857)
27. J.P. Duffy, A. Vardanian, E. Benjamin, M. Watson, D.G. Farmer, and R.M. Ghobrial Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA Ann Surg 246 2007 502 509 (Pubitemid 47312148)
28. F.Y. Yao, L. Xiao, N.M. Bass, R. Kerlan, N.R. Ascher, and J.P. Roberts Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging Am J Transpl 7 2007 2587 2596 (Pubitemid 47561609)
29. C. Jun, X. Xiao, L. Qi, W.U. Jian, and Z. Shu-sen Role of Pittsburgh modified TNM criteria in prognosis prediction of liver transplantation for hepatocellular carcinoma Chin Med J 120 2007 2200 2203
30. K.S. Suh, E.H. Cho, H.W. Lee, W.Y. Chin, N.J. Yi, and K.U. Lee Liver transplantation for hepatocellular carcinoma in patients who do not meet the Milan criteria Dig Dis 25 2007 329 333 (Pubitemid 350014961)
31. J.A. Herrero, B. Sangro, F. Pardo, J. Quiroga, M. Iñarrairaegui, and F. Rottelar Liver transplantation in patients with hepatocellular carcinoma across Milan criteria Liver Transpl 14 2008 272 278 (Pubitemid 351425478)
32. C. Toso, J. Troter, A. Wei, D.L. Bigam, S. Shah, and J. Lancaster Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma Liver Transpl 14 2008 1107 1115
33. M. Silva, A. Moya, M. Berenguer, F. Sanjuan, R. López-Andujar, and E. Pareja Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma Liver Transpl 14 2008 1449 1460
34. V. Mazzaferro, J.M. Llovet, R. Miceli, S. Bhoori, M. Schiavo, and L. Mariani Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol 10 2009 35 42
35. S.J. Pelletier, S. Fu, V. Thyagarajan, C. Romero-Marrero, M. Batheja, and J.D. Punch An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant data Liver Transpl 15 2009 859 868
36. J. Fan, G.S. Yang, Z.R. Fu, Z.H. Peng, Q. Xia, and C.H. Peng Liver transplantation outcome in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China J Cancer Res Clin Oncol 135 2009 1403 1412
37. J.W.C. Chen, L. Kow, D.J. Verran, J.L. McCall, S. Munn, and J.A. Balderson Poorer survival in patients whose explanted hepatocellular carcinoma (HCC) excedes Milano or UCSF criteria. An analysis of liver transplantation in HCC in Australia and New Zealand HBP 11 2009 81 89
38. C. Toso, S. Asthana, D.L. Bigam, M.J. Shapiro, and N.M. Kneteman Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the scientific registry of transplant recipients database Hepatology 49 2009 832 838
39. M. Gabrielli, M. Vivanco, J. Hepp, J. Martínez, R. Pérez, and J. Guerra Liver transplantation results for hepatocellular carcinoma in Chile Transpl Proc 42 2010 299 301
40. J.J. Guiteau, R.T. Cotton, W.K. Washburn, A. Harper, C.A. O'Mahony, and A. Sebastian An early regional experience with expansion of Milan criteria for liver transplant recipients Am J Transpl 10 2010 2092 2098
41. M. Sherman The radiological diagnosis of hepatocellular carcinoma Am J Gastroenterol 105 2010 602 610
42. R.B. Freeman, A. Mithoefer, R. Ruthazer, K. Nguyen, A. Schore, and A. Harper Optimizing staging of hepatocellular carcinoma before liver transplantation: a retrospective analysis of the UNOS/OPTN database Liver Transpl 12 2006 1504 1511 (Pubitemid 44594281)
43. American Liver Tumor Study Group. A randomized prospective multi-institutional trial for orthotopic liver transplantation or partial hepatic resection with or without adjuvant chemotherapy for hepatocellular carcinoma. Investigators booklet and protocol; 1998.
44. J.M. Llovet, J. Fuster, and J. Bruix Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation Hepatology 30 1999 1434 1440
45. F.Y. Yao, N.M. Bass, B. Nicolai, T.J. Davern, R. Kerlan, and V. Wu Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle, and a dropout from the waiting list Liver Transpl 8 2002 873 883 (Pubitemid 35154015)
46. D. Moher, C.S. Dulberg, and G.A. Wells Statistical power, sample size, and their reporting in randomized controlled trials JAMA 272 1994 122 124 (Pubitemid 24206043)
47. J.P. Vandenbroucke Prospective or retrospective: what's in a name? BMJ 302 1991 249 250
48. A.N. Euser, C. Zoccali, K.J. Jager, and F.W. Dekker Cohort studies: prospective versus retrospective Nephron Clin Pract 113 2009 214 217
49. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917 (Pubitemid 37518510)
50. Centre for evidence-based medicine (Oxford, UK). < http://www.cebm.net > [accessed February 2011].
51. Weels GA, Shea B, O'Connel D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. < http://ohri.ca/programs/clinical-epidemiology/oxford.asp > [accessed February 2011].
52. G.H. Guyatt, A.D. Oxman, G. Vist, R. Kunz, Y. Falck-Ytter, and P. Alonso-Coello Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 2008 924 926 (Pubitemid 351632017)
53. Higgins JPT, Green S, editors. Cochrane handbook of systematic reviews of interventions 4.2.6. (updated September 2006). In: The Cochrane Library, Issue 4, Chichester, UK: John Wiley and Sons, Ltd.; 2006.
54. J.P. Higgins, and S.G. Thompson Quantifying heterogenicity in a meta-analysis Stat Med 21 2002 1539 1558
55. P.E. Majno, R. Adan, H. Bismuth, D. Castaing, A. Ariche, and J. Krissat Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis Ann Surg 226 1997 688 701
56. I.W. Graziadei, H. Sandmueller, P. Waldenberger, A. Koeinigsrainer, K. Nachbaur, and W. Jaschke Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on waiting list and leads to excellent outcome Liver Transpl 9 2003 557 563 (Pubitemid 36701690)
57. F.Y. Yao, H. Hirose, J.M. LaBerge, T.J. Daverne 3rd, N.M. Bass, and R.K. Kerlan Jr. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation Liver Transpl 11 2005 1505 1514 (Pubitemid 43072626)
58. M. Ravaioli, G.L. Grazi, F. Piscaglia, F. Trevisani, M. Cescon, and G. Ercolani Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria Am J Transpl 8 2008 2547 2557
59. W.C. Chapman, M.B. Doyle, J.E. Stuart, N. Vachharajani, J.F. Crippin, and C.D. Anderson Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation Ann Surg 248 2008 617 625
60. R.J. Lewandowski, L.M. Kulik, A. Riaz, S. Senthilnathan, M.F. Mulcahy, and R.K. Ryu A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization Am J Transpl 9 2009 1920 1928
61. W. De Luna, D.Y. Sze, A. Ahmed, B.Y. Ha, W. Ayoub, and E.B. Keeffe Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation Am J Transpl 9 2009 1158 1168
62. O. Barakat, R.P. Wood, C.F. Ozaki, V. Ankoma-Sey, J. Galati, and M. Skolkin Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis Liver Transpl 16 2010 289 299
63. J.W. Jang, C.R. You, C.W. Kim, S.H. Bae, S.K. Yoon, and Y.K. Yoo Benefit of downstaging hepatocellular carcinoma in a liver transplantation population Aliment Pharmacol Ther 31 2010 415 423
64. S. Jonas, W.O. Bechstein, T. Steinmüller, M. Hermann, C. Radke, and T. Berg Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis Hepatology 33 2001 1080 1086 (Pubitemid 32378206)
65. T.M. Pawlik, K.A. Delman, J.N. Vauthey, D.M. Nagorney, I.O. Ng, and Y. Yamaoka Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma Liver Transpl 11 2005 1086 1092 (Pubitemid 41341758)
66. P. Therasse, S.G. Arbuck, E.A. Eisenhauer, J. Wanders, R.S. Kaplan, and L. Rubinstein New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 98 2000 205 216 (Pubitemid 30099779)
67. R. Lencioni, and J.M. Llover Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 30 2010 52 60
68. A. Forner, C. Ayuso, M. Varela, J. Rimola, A.J. Hessheimer, and C.R. De Lope Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer 115 2009 616 623
69. E.A. Pomfret, K. Washburn, C. Wald, M.A. Nalesnik, D. Douglas, and M. Russo Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States Liver Transpl 16 2010 262 278
70. G. Otto, S. Herber, M. Heise, A.W. Lohse, C. Mönch, and F. Bittinger Response to transarterial chemoembolization as a biological selection criteria for liver transplantation in hepatocellular carcinoma Liver Transpl 12 2006 1260 1267 (Pubitemid 44194595)
71. G. Millonig, I.W. Graziadei, M.C. Freund, W. Jaschke, S. Stadlmann, and R. Ladurner Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma Liver Transpl 13 2007 272 279 (Pubitemid 46351654)
72. E. Vibert, D. Azoulay, E. Hoti, S. Iacopinelli, D. Samuel, and C. Salloum Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor Am J Transpl 10 2010 129 137
73. U. Cillo, A. Vitale, M. Bassanello, P. Boccagni, A. Brolese, and G. Zanus Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma Ann Surg 239 2004 150 159 (Pubitemid 38176347)
74. U. Cillo, A. Vitale, F. Grigoletto, E. Gringeri, F. D'Amico, and M. Valmasoni Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria Am J Transpl 7 2007 972 981 (Pubitemid 46481197)
75. Y. Hoshida, A. Villanueva, M. Kobayashi, J. Peix, D.T. Chiang, and A. Camargo Gene expressions in fixed tissues and outcome in hepatocellular carcinoma N Eng J Med 359 2008 1995 2004
76. J.S. Lee, I.S. Shu, J. Heo, D.F. Calvisi, Z. Sun, and T. Roskams Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling Hepatology 40 2004 667 676 (Pubitemid 39265589)
77. M. Schwartz, I. Dvorchik, S. Roayaie, I. Fiel, S. Finkelstein, and W. Marsh Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers J Hepatol 49 2008 581 588
78. K. Shirabe, S. Itoh, T. Yoshizumi, Y. Soegima, A. Taketomi, and S. Aishima The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma - with special reference to the serum levels of des-gamma-carboxy prothrombin J Surg Oncol 95 2007 235 240
79. S. Jonas, W.O. Bechstein, T. Steinmmuler, M. Herrmann, C. Radke, and T. Berg Vascular invasion and histopathologic grading determine after liver transplantation for hepatocellular carcinoma in cirrhosis Hepatology 33 2001 1080 1086 (Pubitemid 32378206)
80. G.C. Sotiropoulos, M. Malagó, M. Bockhorn, K.J. Schmitz, A. Radtke, and E.P. Molmenti Liver transplantation for hepatocellular carcinoma and cirrhosis in candidates with undetectable or very low alpha-fetoprotein levels: is an expansion of listing criteria justified? Hepatogastroenterology 55 2008 1671 1677
81. S.S. Zheng, X. Xu, J. Wu, J. Chen, W.L. Wang, and M. Zhang Liver transplantation for hepatocellular carcinoma: Hangzhou experiences Transplantation 85 2008 1726 1732
82. T.M. Pawlik, A.L. Gleisner, R.A. Anders, L. Assumpcao, W. Maley, and M.A. Choti Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy, implications for transplant eligibility Ann Surg 245 2007 435 442 (Pubitemid 46673140)
83. A. Kornberg, M. Freesmeyer, K. Barthel, K. Jandt, K. Katenkamp, and J. Steenbeck 18F-FDG uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients Am J Transpl 9 2009 592 600
84. S. Sumie, R. Kuromatsu, K. Okuda, E. Ando, A. Takata, and M. Fukushima Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors Ann Surg Oncol 15 2008 1375 1382
85. Y. Keike, Y. Shiratori, S. Sato, S. Obi, T. Teratani, and M. Imamura Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 277 patients Cancer 91 2001 561 569 (Pubitemid 32105702)
86. J.M. Llovet, J. Bustamante, A. Castells, R. Vilana, M.delC. Ayuso, and M. Sala Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials Hepatology 29 1999 62 67 (Pubitemid 29023987)
87. M.L. Volk, S. Vijan, and J.A. Marrero A novel model measuring of transplanting hepatocellular carcinoma exceeding Milan criteria Am J Transpl 8 2008 839 846 (Pubitemid 351347750)